Literature DB >> 21450835

Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens.

Madhuri Subbiah1, Sunil K Khattar, Peter L Collins, Siba K Samal.   

Abstract

Avian paramyxovirus serotype 2 (APMV-2) is one of the nine serotypes of APMV, which infect a wide variety of avian species around the world. In this study, we constructed a reverse genetics system for recovery of infectious recombinant APMV-2 strain Yucaipa (APMV-2/Yuc) from cloned cDNA. The rescued recombinant virus (rAPMV-2) resembled the biological virus in growth properties in vitro and in pathogenicity in vivo. The reverse genetics system was used to analyze the role of the cleavage site of the fusion (F) protein in viral replication and pathogenesis. The cleavage site of APMV-2/Yuc (KPASR↓F) contains only a single basic residue (position -1) that matches the preferred furin cleavage site [RX(K/R)R↓]. (Underlining indicates the basic amino acids at the F protein cleavage site, and the arrow indicates the site of cleavage.) Contrary to what would be expected for this cleavage sequence, APMV-2 does not require, and is not augmented by, exogenous protease supplementation for growth in cell culture. However, it does not form syncytia, and the virus is avirulent in chickens. A total of 12 APMV-2 mutants with F protein cleavage site sequences derived from APMV serotypes 1 to 9 were generated. These sites contain from 1 to 5 basic residues. Whereas a number of these cleavage sites are associated with protease dependence and lack of syncytium formation in their respective native viruses, when transferred into the APMV-2 backbone, all of them conferred protease independence, syncytium formation, and increased replication in cell culture. Examination of selected mutants during a pulse-chase experiment demonstrated an increase in F protein cleavage compared to that for wild-type APMV-2. Despite the gains in cleavability, replication, and syncytium formation, analysis of viral pathogenicity in 9-day-old embryonated chicken eggs, 1-day-old chicks, and 2-week-old chickens showed that the F protein cleavage site mutants did not exhibit increased pathogenicity and remained avirulent. These results imply that structural features in addition to the cleavage site play a major role in the cleavability of the F protein and the activity of the cleaved protein. Furthermore, cleavage of the F protein is not a determinant of APMV-2 pathogenicity in chickens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450835      PMCID: PMC3094964          DOI: 10.1128/JVI.02696-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation.

Authors:  S Krishnamurthy; Z Huang; S K Samal
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

Review 2.  Newcastle disease and other avian paramyxoviruses.

Authors:  D J Alexander
Journal:  Rev Sci Tech       Date:  2000-08       Impact factor: 1.181

3.  Avian influenza A and paramyxo viruses complicating respiratory disease diagnosis in poultry.

Authors:  R A Bankowski; R D Conrad; B Reynolde
Journal:  Avian Dis       Date:  1968-05       Impact factor: 1.577

4.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Generation of recombinant lentogenic Newcastle disease virus from cDNA.

Authors:  Angela Römer-Oberdörfer; Egbert Mundt; Teshome Mebatsion; Ursula J Buchholz; Thomas C Mettenleiter
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

6.  Complete nucleotide sequence of avian paramyxovirus type 6 isolated from ducks.

Authors:  P-C Chang; M-L Hsieh; J-H Shien; D A Graham; M-S Lee; H K Shieh
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

7.  The viral replication complex is associated with the virulence of Newcastle disease virus.

Authors:  J C F M Dortmans; P J M Rottier; G Koch; B P H Peeters
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

8.  Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.

Authors:  Zhuhui Huang; Sateesh Krishnamurthy; Aruna Panda; Siba K Samal
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity.

Authors:  Angela Römer-Oberdörfer; Ortrud Werner; Jutta Veits; Teshome Mebatsion; Thomas C Mettenleiter
Journal:  J Gen Virol       Date:  2003-11       Impact factor: 3.891

10.  Role of fusion protein cleavage site in the virulence of Newcastle disease virus.

Authors:  Aruna Panda; Zhuhui Huang; Subbiah Elankumaran; Daniel D Rockemann; Siba K Samal
Journal:  Microb Pathog       Date:  2004-01       Impact factor: 3.738

View more
  13 in total

1.  Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.

Authors:  Shin-Hee Kim; Madhuri Subbiah; Arthur S Samuel; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

2.  Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducks.

Authors:  Shin-Hee Kim; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

3.  Mutation of the f-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens.

Authors:  Sa Xiao; Sunil K Khattar; Madhuri Subbiah; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

4.  Virulence of Newcastle disease virus: what is known so far?

Authors:  Jos C F M Dortmans; Guus Koch; Peter J M Rottier; Ben P H Peeters
Journal:  Vet Res       Date:  2011-12-23       Impact factor: 3.683

Review 5.  Paramyxovirus fusion and entry: multiple paths to a common end.

Authors:  Andres Chang; Rebecca E Dutch
Journal:  Viruses       Date:  2012-04-19       Impact factor: 5.048

6.  Characterization of novel avian paramyxovirus strain APMV/Shimane67 isolated from migratory wild geese in Japan.

Authors:  Eiji Yamamoto; Hiroshi Ito; Yukiko Tomioka; Toshihiro Ito
Journal:  J Vet Med Sci       Date:  2015-04-11       Impact factor: 1.267

7.  Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 4 confer increased replication and syncytium formation in vitro but not increased replication and pathogenicity in chickens and ducks.

Authors:  Shin-Hee Kim; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

8.  Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaques.

Authors:  Sunil K Khattar; Baibaswata Nayak; Shin-Hee Kim; Sa Xiao; Sweety Samal; Anandan Paldurai; Ursula J Buchholz; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

9.  Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger.

Authors:  Ruben M Markosyan; Chunhui Miao; Yi-Min Zheng; Gregory B Melikyan; Shan-Lu Liu; Fredric S Cohen
Journal:  PLoS Pathog       Date:  2016-01-05       Impact factor: 6.823

10.  Comprehensive analysis of amino acid sequence diversity at the F protein cleavage site of Newcastle disease virus in fusogenic activity.

Authors:  Yanhong Wang; Wanqi Yu; Na Huo; Wenbin Wang; Yuanyuan Guo; Qiaolin Wei; Xinglong Wang; Shuxia Zhang; Zengqi Yang; Sa Xiao
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.